337508-71-1 Usage
Uses
Used in Pharmaceutical Industry:
2,3-Dihydro-1,4-benzodioxine-6-carbothioamide is used as a potential therapeutic agent for treating clotting disorders and preventing blood clots due to its antithrombotic and anticoagulant activities.
Used in Research and Development:
In the field of research and development, 2,3-Dihydro-1,4-benzodioxine-6-carbothioamide is used for exploring new medication and therapies related to cardiovascular diseases, leveraging its potential impact on clotting mechanisms and blood flow.
Used in Organic Chemistry:
2,3-Dihydro-1,4-benzodioxine-6-carbothioamide is utilized as a reagent in organic chemistry reactions, contributing to the synthesis of other compounds for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 337508-71-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,7,5,0 and 8 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 337508-71:
(8*3)+(7*3)+(6*7)+(5*5)+(4*0)+(3*8)+(2*7)+(1*1)=151
151 % 10 = 1
So 337508-71-1 is a valid CAS Registry Number.
InChI:InChI=1/C9H9NO2S/c10-9(13)6-1-2-7-8(5-6)12-4-3-11-7/h1-2,5H,3-4H2,(H2,10,13)
337508-71-1Relevant articles and documents
Novel thiazole derivatives as inhibitors of superoxide production by human neutrophils: Synthesis and structure-activity relationships
Chihiro,Nagamoto,Takemura,Kitano,Komatsu,Sekiguchi,Tabusa,Mori,Tominaga,Yabuuchi
, p. 353 - 358 (2007/10/02)
Neutrophils have an important role in the self-defense systems of organisms through the production of superoxide. On the other hand, it has been proposed that abnormal amounts of superoxide produced by neutrophils are a serious factor in tissue injury. A series of novel thiazole derivatives was prepared and evaluated inhibitory effect on superoxide production by human neutrophils in vitro. Among these compounds, 6-[2-(3,4- diethoxyphenyl)thiazol-4-yl]-pyridine-2-carboxylic acid (OPC-6535) was selected as one of the most promising compounds. The synthesis and structure- activity relationships of these compounds are reported herein.
Xn:Harmful;
